Back to search

National and Kapodistrian University of Athens

Activation of type I and II interferon pathways in sicca syndrome

Abstract

dc:description

Sjögren's disease (SjD) is a systemic and chronic autoimmune disease affecting predominantly middle-aged females. It is characterized by lymphoid infiltration of exocrine glands, primarily the salivary and lacrimal glands, which lead to their dysfunction. Although it is considered mainly a localized disease of the exocrine glands, it can affect virtually any other organ system. The clinical manifestations are divided into those related to exocrine gland dysfunction (glandular) and those affecting other organs (extra-glandular or systemic manifestations). The majority of these patients have an indolent and benign course, while a small but significant percentage of them develop non-Hodgkin Lymphoma (NHL).The primary etiopathogenic event of SjD is unknown. However, it is widely accepted that its pathogenesis is the result of environmental insults, such as infections, chemical and/or physical agents, hormonal alterations, and stressful life events in genetically predisposed individuals, all of which led to periepithelial lymphocytic infiltrations across different organs (salivary and lacrimal glands, biliary ducts, renal tubules, bronchi). As a result, the term “Autoimmune Epithelitis” was proposed.Interferons (IFNs) have been previously shown to significantly contribute to the pathophysiology of several autoimmune disorders, including SjD. High serum levels of interferon activity have been documented in SjD patients, and upregulation of genes induced by type I and type II IFNs have been previously found to predominate in peripheral blood (PB) as well as in the salivary gland tissues of patients with SjD, respectively. Distinct transcriptional patterns of systemic and salivary gland IFN have also been detected, and the IFNγ/IFNα mRNA ratio in labial minor salivary glands (LMSGs) was found to be able to distinguish SjD patients with NHL from SjD patients without NHL and patients with sicca symptoms. To our knowledge, however, so far, it has not been recognized that a single IFN related gene distinguishes SjD patients with NHL from those without NHL and thus could serve as an easy biomarker in clinical practice. In the current study, transcriptomic analysis was implemented to identify potential novel biomarkers in the IFN pathway denoting the presence of lymphoma in the setting of SjD. The relationship between the IFN signature in LMSGs and the PB of SjD patients was also investigated. Interferon Stimulated Gene 15 (ISG-15) gene expression was able to distinguish SjD patients without NHL and SjD patients with NHL at both the periphery and tissue level and therefore could represent a novel biomarker for lymphoma development among SjD patients. Additionally, type I, but not type II, IFN-induced gene expression in LMSGs correlates well with gene expression in PB, denoting a common transcriptional profile of the type I IFN pathway in LMSGs and PB.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Cinoku, Ilir
  • Τσινόκου, Ιλίρ

Subjects

dc:subject × 16

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60529

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Cinoku, Ilir; Τσινόκου, Ιλίρ. Activation of type I and II interferon pathways in sicca syndrome. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/60529